Introduction
Obesity has become a major public health problem worldwide, and its prevalence has dramatically increased over several decades. [1] Furthermore, it is associated with other diseases such as nonalcoholic fatty liver, type 2 diabetes, hypertension, coronary artery disease, and various forms of cancer. [2, 3] A growing body of evidence has shown that gut microbiota plays a critical role in nutrient acquisition, energy harvest, and lipid metabolism, which may contribute to the metabolic diseases. [4] [5] [6] In addition, it has been reported recently that foods and their functional ingredients have the potential to alter gut microbiota composition and so as to modulate lipid metabolism and prevent obesity. [7, 8] Therefore, gut microbiota may become a potential new target for control of obesity.
Tea is one of the most widely consumed flavored and functional beverages in the world. [9, 10] The health-promoting effects of tea consumption, including protection against cancer, prevention of cardiovascular diseases, and alleviation of metabolic syndrome, have been well studied. [11] Kudingcha (KDC) from Ilex kudingcha is a popular herb beverage alternative to Camellia tea in Eastern and Southeastern Asia. [12] KDC and Fuzhuan brick tea (FBT) are two of the most popular herb beverages with the reputation of antiobesity in China, and the preventive and therapeutic roles in metabolic disorders have been demonstrated. [13] [14] [15] [16] Polyphenols and polysaccharides are considered as the main functional ingredients in tea and KDC, which contribute to the most of the observed beneficial effects. [10, 11, 17, 18] Both polyphenols and polysaccharides have been revealed generally poor absorption, therefore, the indigestible polyphenols and polysaccharides can reach the large intestine and be utilized by gut microbiota, which may contribute to the health-promoting activities. [17] In the recent years, the researchers pay more and more attention to the effects of tea on the gut microbiota. [19, 20] For example, black, Oolong, and green teas could alter the structure of gut microbiota in high-fat-diet (HFD) fed mice, including Parabacteroides, Allobaculum, Bacteroides, Akkermansia, Lachnospiraceae, Alistipes, and Rikenella. [21] Likewise, FBT could also alter gut microbiota in HFD-induced rats with a threefold increase in two Lactobacillus spp. [22] However, the potential role of gut microbiota modulated by FBT in the prevention of obesity is still not clearly understood. Furthermore, relationship between the gut microbiota modulatory effect of KDC and prevention of obesity is still limited. In the present study, therefore, our aim was to understand whether the oral administration of KDC and FBT could modulate the gut microbiota composition of HFD fed mice through high-throughput sequencing analysis, then find gut microbes responding to dietary intervention of HFD, KDC, and FBT, as well as investigate whether they are associated with preventation of obesity.
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Processing Factory Co., Ltd. (Yiyang, Hunan Province, China), respectively. Both KDC and FBT were extracted by using boiled water and then lyophilized, affording KDC and FBT extracts. Thereinto, KDC extract consisted of 10.24 ± 0.36% soluble sugars, 5.70 ± 0.04% polysaccharides, 45.4 ± 1.7% polyphenols, 10.81 ± 1.5% crude proteins, and 7.62 ± 1.06% flavonoids. FBT extract consisted of 7.13 ± 0.58 % soluble sugars, 3.84 ± 0.25% polysaccharides, 26.05 ± 1.15% polyphenols, 7.58 ± 0.8% crude proteins, and 5.26 ± 1.06% flavonoids. Thirty-two male C57BL/6 mice (6 weeks of age, body weight 19.69 ± 0.85 g). The animal number was NO.201608240) were purchased from Comparative Medicine Centre of Yangzhou University (Yangzhou, China, SCXK<Jiangsu>2012-0004) and randomly divided into four treatment groups (eight mice per group) in specific pathogenfree condition. The mice of first group were fed with normal diet (ND, 10% calories from fat, MD12031) with administration of water (200 μL) as control. The mice of second group were fed HFD (45% calories from fat, MD12032) with administration of water (200 μL) as model control. The mice of other two groups were maintained on HFD and given an administration of 400 mg kg -1 d -1 (200 μL) KDC extract (HFD-KDC) or FBT extract (HFD-FBT) for 8 weeks by intragastric gavage after acclimatization for 1 week. All the mice were housed in cages under controlled light conditions (12 h light-dark cycle) and had ad libitum access to diet and water. The experimental procedure and protocol were approved by and performed in Animal Experiment Center of Nanjing Agricultural University (Nanjing, China, SYXK<Jiangsu>-2011-0036) according to the National Guidelines for Experimental Animal Welfare (Ministry of Science and Technology of the People's Republic of China, 2006) . The diets were purchased from Jiangsu Medicience Ltd. (Yangzhou, China), and the compositions are shown in Supporting Information Table S1 . The food intake and body mass were measured weekly. The feces, liver, serum, perirenal adipose tissue, and epididymal adipose tissue were collected at the end of experiment, immediately frozen in liquid nitrogen, and stored at -80°C.
Biochemical Analysis, Endotoxemia, and Cytokine Measurements
The levels of triglyceride (TG), total cholesterol (TC), LDLcholesterol (LDL-C), and HDL-cholesterol (HDL-C) in serum and the contents of TG, malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSHPx) in liver were measured by commercially available kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). Commercial ELISA kits were used to determine the levels of tumour necrosis factor-alpha (TNF-α), IL-6, LPS, and C-reactive protein (CRP) in serum (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).
Quantification of Host Gene Expression
The relative expressions of hepatic lipid metabolism related genes at mRNA level in liver were measured and calculated with SYBR Green and Ct methods. The target genes including carnitine palmitoyl transterase-1 (CPT-1), peroxisome proliferatoractivated receptor α (PPARα), peroxisome proliferator-activated receptor γ (PPARγ ), sterol regulatory element binding protein1c (SREBP-1c), fatty acid synthase (FAS), and liver X receptor α (LXRα) and their primer sequences are shown in Supporting Information Table S2 . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as reference gene.
Analysis of Fecal Bacterial Composition by Pyrosequencing
Fecal genomic DNA was extracted by QiAamp DNA stool Mini Kit (NO.51504, Qiagen, Germany). The resulting DNA was amplified with barcoded specific bacterial primers targeting the 16S rRNA gene V4 region using primers with the Primer F 515 (Illumina adapter sequence 1 + AYTGGGYDTAAAGNG) and Primer 806 R (Illumina adapter sequence 2 + TACN-VGGGTATCTAATCC). For each fecal sample, the sequencing and bioinformatics analysis were carried out by Genesky Biotechnologies Inc. (Shanghai, China) on the Illumina MiSeq platform to generate 2 × 250 bp paired-end reads. The raw reads were quality filtered and merged with the following criteria: (1) Truncation of the raw reads at any site with an average quality score <20, removal of reads contaminated by adapter, and further removal of reads having less than 100 bp by TrimGalore, (2) the paired end reads are merged to tags by Fast Length Adjustment of Short reads (FLASH, v1.2.11), [23] (3) removal of reads with ambiguous basa (N base) and reads with more than 6 bp of homopolymer by Mothur, [24] and (4) removal of reads with low complexity to obtain clean reads for further bioinformatics analysis. The remaining unique reads were chimera checked compared with the gold.fa database (http://drive5.com/uchime/gold.fa) and clustered into operational taxonomic units (OTUs) by UPARSE with 97% similarity cutoff. [25] All OTUs were classified based on Ribosomal Database Project Release9 201203 by Mothur. [24] Rarefaction analysis and alpha diversities (including Shannon, Simpson, and InvSimpson index) were analyzed by Mothur. [24] Sample tree cluster by Bray-Curtis distance matrix and unweighted pair-group method with arithmetic means and Jaccard principal coordinate analysis (PCoA) based on OTUs were performed by R Project (Vegan package, V3.3.1). Redundancy analysis (RDA) was analyzed by Canoco for Windows 4.5 (Microcomputer Power, NY, USA), which was assessed by MCPP with 499 random permutations.
Statistical Analysis
The data are presented as mean ± SD. One-way analysis of variance procedure followed by Tukey test was used to evaluate the statistical significance by SPSS 22 software (IBM, Chicago, USA). Differences in relative abundance of OTUs were calculated using the MannWhitney test by R package (V3.3.1). Furthermore, adjusted p-values obtained based on false discovery rate were used to evaluate differences in differential abundance. A value of p < 0.05 was considered to be significant in this work.
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FBT and KDC Attenuated Features of Obesity in HFD-Fed Mice
To examine the effects of FBT and KDC on the development of obesity, the male C57BL/6 mice were fed with HFD and an administration of 400 mg kg -1 d -1 FBT or KDC extract. During the 8-week feeding trial, significant increases in body weight, accumulation of epididymal and perirenal fats, liver weight as well as content of TG in liver were observed after HFD feeding (Figure 1 ). Dietary supplementation with FBT or KDC extract could significantly attenuate body weight gain, which coincided with significant reductions in accumulation of epididymal and perirenal fats, liver weight, and content of TG in liver. Particularly, the weights of body, perirenal fat, liver weight, and content of TG in liver for HFD-FBT group had no significant difference in comparison with those of ND group (p > 0.05), and the liver weight and content of TG in liver for HFD-KDC also had no significant difference with those of ND (p > 0.05). However, there was no significant difference in the food intake between HFD group and tea intervention groups (Supporting Information Figure S1 ).
The results for biochemical measurements of serum including TG, TC, LDL-C, and HDL-C levels are shown in Figure 2 . It was observed that HFD led to significant increases in TC and LDL-C levels ( Figure 2A , C), and significant decrease in HDL-C level ( Figure 2D ). Supplementation of FBT extract could significantly decrease TG and LDL-C levels. However, the levels of serum TC and HDL-C did not affected by treatment of FBT or KDC extract. The results suggested that FBT extarct could attenuate features of blood lipid in HFD-fed mice, while KDC extract showed limited effect on blood lipid levels.
Effects of FBT and KDC on Liver Oxidative Damage, Serum Inflammation, and Endotoxemia in HFD-Fed Mice
It has been reported that HFD intervention can lead to a higher oxidative stress in liver, which contributes to hepatic lipid accumulation and thereby results in many other diseases in liver. [26, 27] Therefore, regulation of hepatic oxidative stress by antiobesogenic candidates is considered to have an important role in alleviation of obesity. [11] Thereinto, antioxidant enzymes in liver such as SOD, CAT, and GSH-Px play an important role in controlling lipid peroxidation, which contribute to the major defense against reactive oxygen species. [28] Therefore, hepatic parameters of oxidative stress in mice were measured as shown in Supporting Information Figure S2 . The decreased levels of SOD, CAT, and GSH-Px and an increased level of MDA were observed in liver after HFD intervention. Both KDC and FBT could significantly prevent the HFD-induced changes in hepatic parameters of oxidative stress including decrease in MDA level and increases in levels of SOD, CAT, and GSH-Px in liver. The increased levels of pro-inflammatory cytokines and endotoxemia have been reported to be related to obesity-related disorders in HFD-induced obese mice. [29, 30] As expected, we observed higher levels of LPS, TNF-α, IL-6, and CRP in serum after HFD treatment compared with those of ND group (Supporting Information Figure S3 ). Both KDC and FBT intervention could normalize the levels of TNF-α and CRP, which showed no difference compared with ND group (p > 0.05). Furthermore, KDC and FBT could significantly ameliorate the HFD-induced high levels of LPS and IL-6 compared with HFD group (p < 0.05).
FBT and KDC Regulated Expressions of Lipid Metabolism Related Genes
Previous studies have shown that expression of genes involved in hepatic fatty acid synthesis and oxidation could be changed by HFD treatment. [29, 31] Therefore, the expression levels of CPT-1, PPARα, PPARγ , SREBP-1c, FAS, and LXRα were evaluated by real-time quantitative PCR to investigate whether FBT or KDC regulate the metabolic syndrome in HFD-fed mice (Figure 3) . The HFD treatment led the up-regulation of LXRα, FAS, SREBP1c, and PPARγ , and the downregulation of CPT-1 and PPARα compared with ND group. Both FBT and KDC could significantly reduce the expression levels of FAS, SREBP-1c, and PPARγ (p < 0.05). However, the expression levels of LXRα, CPT-1, and www.advancedsciencenews.com www.mnf-journal.com PPARα showed no difference with those of HFD group treated with FBT or KDC extract (p > 0.05).
Overall Structural Change of Gut Microbiota in Response to HFD, FBT, and KDC
In this work, pyrosequencing of variable region 4 (V4) of bacterial 16S rRNA genes was performed to investigate the impact of HFD, FBT, and KDC on mice gut microbiota. The clean reads of the 32 samples (n = 8 for each group) were all more than 44 397, and 3209 distinct OTUs were observed. The Rarefaction and Shannon index curves revealed that the data had covered most of the diversity and new phylotypes (Supporting Information Figure S4 ). As expected, furthermore, the diets palyed a key role in shaping phylogenetic diversity [32] based on the α-diversity including Shannon, Simpson, and InvSimpson index. The HFD significantly decreased the phylogenetic diversity of fecal microbiota, suggesting possible deficiency of healthy microflora after HFD treatment, [33] which is in agreement with previous findings.
[ 21] Nevertheless, both FBT and KDC could ameliorate the microbiota phylogenetic diversity (Supporting Information Figure S5 ). Thereinto, Shannon, Simpson, and InvSimpson indices were significantly reversed (p < 0.05) after KDC treatment, which exhibited no difference with those of ND group (p > 0.05). Furthermore, KDC exhibited better effect on amelioration of the gut microbiota phylogenetic diversity.
PCoA and sample tree cluster based on OTUs abundance were used to show a distinct clustering of gut microbiota compositions from different treatments. The results showed that HFD group separately clustered from that of ND group (Figure 4A ). Significant separation was also noted for HFD, HFD-FBT, and HFD-KDC groups, indicating that FBT and KDC had substantial effects on gut microbiota composition of HFD-fed mice. Moreover, PC1, accounting for 19.81% of total variance that showed a higher total variance than that of PC2 accounting for 9.64%, suggested that FBT and KDC could shift the HFD-disrupted gut microbiota composition towards that of ND group, indicating that PC1 could reflect the effect of diet on the composition of gut microbiota. [34] It has been reported that diets play a dominant role to shape the structure of gut microbiota. [35] Thus, FBT and KDC could turn gut microbiota composition of HFD group back to normal status based on PC1. As expected, significant separation was also observed in the results of sample tree cluster for ND, HFD, HFD-KDC, and HFD-FBT groups, which is consistent with the result of PCoA ( Figure 4B ). Taxonomic profiling suggested that the gut microbiota structure of mice was mainly dominated by Firmicutes and Bacteroidetes at phylum level ( Figure 4C ), which is consistent with report of literature. [29, 36, 37] The gut microbial community structure could be obviously changed by HFD, with Firmicutes relative abundance increased and Bacteroidetes relative abundance decreased ( Figure 4D ). Therefore, the HFD feeding induced significant increase in the ratio of Firmicutes to Bacteroidetes compared to ND group (p < 0.05). Nevertheless, FBT could signicantly attenuate this increase to the level similar to ND group (p > 0.05). However, KDC exhibited limited effect on the ratio of Firmicutes to Bacteroidetes. At family level, siginificant shifts in Porphyromonadaceae, Rikenellaceae, Lactobacillaceae, Erysipelotrichaceae, and Coriobacteriaceae after supplementation with HFD were observed compared with ND group (p < 0.05) (Supporting Information Figure S6 ). KDC treatment could reduce the relative abundances of Erysipelotrichaceae and Coriobacteriaceae to the levels of ND group (p > 0.05). Apart from modulation of Porphyromonadaceae and Coriobacteriaceae, FBT could enhance the relative abundance of Bifidobacteriaceae, which is considered as health-promoting species. [34] It is important to identify the changes of OTU-level phylotypes after KDC or FBT treatment, due to the fact that the different bacterial species in the same family have different responses to the same environmental stressor such as HFD. [34, 38] Bacterial functions and their roles in metabolic diseases are strain specific. [39] Therefore, OTUs with relative abundance more than 0.1% at least in one group were analyzed based on redundancy analysis model to identify specific bacterial phylotypes, which were changed by HFD, FBT, or KDC feeding. As results, 122 OTUs were significantly altered by HFD treatment including 69 increased and 53 decreased OTUs compared with those of ND group (Supporting Information Figure S7A ). KDC and FBT treatments changed 38 www.advancedsciencenews.com www.mnf-journal.com (22 increased and 16 decreased) and 74 (37 increased and 37 decreased) OTUs (Supporting Information Figure S7B , C), respectively, resulting in significant changes of 100 OTUs in total. The results were sumarized by Venn diagrams (Supporting Information Figure S8 ). Among the 100 OTUs, 64 OTUs changed by HFD treatment were reversed changes by KDC or FBT (Supporting Information Data 1 and Figure 5) . Thereinto, KDC and FBT treatments reversed 30 and 58 OTUs, respectively. FBT treatment was more effective than KDC treatment for modulating the gut microbiota induced by HFD.
Discussion
Obesity is associated with many diseases, such as heart disease, dyslipidaemia, cancer, and type 2 diabetes. [40] In recent years, a growing body of animal and human studies showed that dietary supplementation with tea was a potentially viable nutritional strategy for the prevention of obesity. [11] It has been demonstrated that FBT and KDC consumption could prevent weight gain and metabolic disorders induced by HFD feeding. [13, 14, [41] [42] [43] Furthermore, Lactobacillus johnsonii and another Lactobacillus sp. in high saturated fat diet-fed rats could be enhanced by FBT intake. [22] However, the potential role of gut microbiota modulated by KDC and FBT in the prevention of obesity is still not clearly understood. In order to focus on the effects of KDC and FBT on modulation of gut microbiota in HFD-fed mice, KDC and FBT were tested individually for their capacities to prevent obesity and modulate the gut microbiota using obesity-prone C57BL/6J mice model, but the groups fed standard diet with administration of KDC or FBT were not included in the present study. As expected, both KDC and FBT supplementation exhibited suppressive effects on body weight gain, fat accumulation, liver weight as well as content of TG in liver induced by HFD treatment. Plasma lipids levels, including TG and LDL-C which are considered to be associated with obesity, were also significantly reduced with administration of FBT. The results are consistent with the reports for other teas. It has been reported that black, Oolong, and green teas could significantly reduce body weight gain and fat accumulation in mice fed with HFD. [21] Furthermore, tea polysaccharides, polyphenols, and caffeine from green tea could prevent the development of obesity in HFD fed rats. [44] It has been reported that HFD-induced gut dysbiosis resulted in damage of intestinal integrity and release of LPS from intestinal Gram-negative bacteria into the bloodstream, which could lead to insulin resistance, metabolic inflammation, and obesity. [29] Previous studies demonstrated that the levels of pro-inflammatory cytokines were significantly enhanced after HFD intervention. [34] In this work, both KDC and FBT could attenuate the HFD-induced oxidative injury, endotoxemia, and inflammation in mice. Previous reports showed that antiobesogenic candidates could not only prevent the fat accumulation, but also regulate the oxidative stress, endotoxemia, and inflammation. [11, 45] For KDC, phenolics, saponins, and polysaccharides were the main beneficial components. [13, 46, 47] Unlike other teas, a series of special bioactive constituents (such as theabrownines) were synthesized during the microbial fermentation stage of FBT production, and those special constituents might contribute to the antiobesity activity of FBT. [16, 48] In the present study, no significant difference in the food intake of mice between HFD group and tea intervention group was observed, which suggested that the antiobesogenic effects of KDC and FBT were not induced by reduced food consumption. [29] The liver is the most important organ for lipogenesis and metabolism of lipids and energy. [49] Accumulated evidences indicate that HFD-induced obesity can alter lipogenic gene expression levels in liver, such as PPARγ , CPT-1, PPARα, SREBP-1c, FAS, and LXRα. [29, 31] Furthermore, lots of antiobesogenic candidates were reported to alleviate obesity and serum lipid levels via simultaneous regulation of gene expression levels associated with fatty acid synthesis and lipid metabolism. [31, 50, 51] Therefore, regulation of hepatic gene expression might play an important role in inhibition of fat accumulation after KDC or FBT intervention. SREBP1-c, a well-known critical transcription factor, is involved in adipocyte differentiation and adipogenesis in the liver via regulating expression of the downstream marker molecules, FAS, for example, providing nonesterified fatty acid substrate for triacylglycerol to result in the enhancement of fatty acid synthesis and accumulation of TG. [50, 52] Furthermore, SREBP1-c can increase the reactive oxygen species level and aggravate inflammatory injury in liver tissues. [53] PPARγ is a known regulator for fatty acid oxidation and whole-body lipid metabolism, and a downregulation of PPARγ expression or activity could result in stimulating lipolysis and suppressing fatty acid synthesis and TG level in liver. [31] Our present work revealed that KDC and FBT could significantly reduce the hepatic expression levels of PPARγ , SREBP-1c, and FAS. Therefore, the present results suggested that KDC and FBT might prevent the body weight gain, fat accumulation, and increase of plasma lipid levels by inhibiting adipogenic gene expression. It has been reported that combination of citrus polymethoxyflavones, green tea polyphenols, and Lychee extracts could protect against HFD-induced obesity via downregulation of PPARγ , SREBP-1c, and FAS. [52] Tea polyphenols are generally poorly absorbed, and the beneficial health effects of tea may ascribe to the metabolites of polyphenols by gut microbiota. [17, 54] Moreover, the gut microbiota may regulate energy harvest, which is related to obesity. [4, 5] Therefore, we hypothesized that KDC and FBT might prevent body weight gain and fat accumulation through modulating the gut microbiota. It has been reported that obese individuals has lower microbial diversity than lean individuals. [36, 55] Our present results showed that KDC and FBT could enhance the microbial diversity, which is in accordance with the report that green tea could significantly increase the the microbial diversity (Shannon index). [21] Moreover, HFD administration could lead to typical obesity-driven dysbiosis in the gut microbiota by increasing Firmicutes relative abundance and decreasing Bacteroidetes relative abundance. [56, 57] On the other hand, supplementation with polyphenols, polysaccharides, and other functional ingredients could reduce the ratio of Firmicutes to Bacteroidetes, which contributed to the prevention of body weight gain induced by HFD. [37, 58] In the present study, FBT could significantly reduce the ratio of Firmicutes to Bacteroidetes, suggesting that the modulation of gut microbiota to decrease the energy harvest might contribute to attenuating the obesity induced by HFD.
Previous work showed that Erysipelotrichaceae was associated with obese individuals or HFD fed mice, [32, 59] and it was also related to lipidemic profiles within the host. [60] In addition, it was www.advancedsciencenews.com www.mnf-journal.com www.advancedsciencenews.com www.mnf-journal.com found that the level of Erysipelotrichaceae in human study or animal model was related to inflammatory bowel disease. [60] It has been reported that the decrease of Erysipelotrichaceae level by plant sterol esters in hamsters model might contribute to host lipid metabolism. [61] In the present study, it was found that KDC could reduce the relative abundance of Erysipelotrichaceae to the level of ND group (p > 0.05). Therefore, antiobesity activity of KDC might be due to the decrease in relative abundance of Erysipelotrichaceae. Bifidobacterium spp. has been reported to be able to reduce obesity. [34, 62] Furthermore, Cani et al. reported that only Bifidobacterium spp. in HFD fed mice was significantly and negatively correlated with endotoxaemia analyzed by multiple correlation, and other altered bacterial group by oligofructose had no relationship with endotoxaemia. [30] Thus, the increased relative abundance of Bifidobacteriaceae by FBT administration might contribute to the prevention of obesity. It has been reported that the relative abundance of Lactobacillus spp. showed a threefold increase due to FBT intervention in high saturated fat dietfed rats. [22] However, the increase in the relative abundance of Lactobacillus spp. was not found for treatment with KDC or FBT in the present study, which might be due to the different animal models and HFDs.
Among the 64 key OTUs reversed by FBT or KDC, potential benificial effects of KDC and FBT on microbiota in genus level were analyzed. Our results indicated that the significant reductions in the proportions of Anaerotruncus (OTU0055 and OTU0556), Alistipes (OTU0093 and OTU0054) and Odoribacter (OTU008, OTU0011, and OTU0078) in HFD group, which has been reported to be associated with benefical effects, [21, 29, 40] were enriched by KDC or FBT treatment. Conversely, the enhanced bacterial levels of Clostridium IV (OTU0267, OTU0288, and OTU0358), Clostridium XIVb (OTU0025), Oscillibacter (OTU0019, OTU0042, and OTU0141), Bilophila (OTU0196), Eisenbergiella (OTU0027), Lactonifactor (OTU0479), Leuconostoc (OTU0216), Olsenella (OTU0260), Pseudoflavonifractor (OTU0012), and Streptococcus (OTU0406) in HFD group were reduced after administration of KDC or FBT. Some microbial communities such as Bilophila, Oscillibacter, and Clostridium XIVb have been proven to be positively correlated with obesity and inflammation. [34, 63, 64] The present results demostrated that the antiobesity activity of KDC or FBT might be associated with moduation of these gut microbiota.
The current model of the obesity and chronic inflammation induced by HFD has been reported to be largely due to the increased serum level of metabolic endotoxemia and gut microbiota dysbiosis. [29, 65] Our previous studies showed that dicaffeoylquinic acids in KDC could remain intact in simulated saliva, gastric, and pancreatic fluids and within Caco-2 cells, and exhibit modulating effects in vitro on gut microbiota through the fermentation in large intestine. [54, 66] Furthermore, polysaccharides from fuzhuan brick tea could reach safely the large intestine without being broken down in simulated digestive system, then the polysaccharides could be broken down and utilized by gut microbiota resulting in significant modulation of gut microbiota. [67] Therefore, it is hypothesized that the possible mechanism of obesity prevention by KDC or FBT might be that the indigestible compositions of KDC or FBT reached the large intestine and then modulated the gut microbiota. Furthermore, our present results indicated that KDC or FBT supplementation could also modulate the oxidative stress, decrease inflammation, and reduce endotoxemia in HFD-induced obese mice, which might contribute to the antiobesogenic effects of FBT and KDC. However, the mechanisms of gut microbiota modulation and obesity prevention by ingredients in KDC or FBT should be further investigaed in detail. It has been reported that metabolites by gut microbiota, such as short-chain fatty acids, play an important role in metabolic health. [68] [69] [70] In the future, it would be interesting to determine the metabolites of KDC and FBT in large intestine and ensure whether these molecules contribute to the antiobesity activity.
In conclusion, both KDC and FBT could attenuate oxidative injury, inflammation, body weight gain, and fat accumulation in HFD-fed mice. Furthermore, the structural alteration of gut microbiota induced by HFD treatment could be modulated by KDC and FBT, which might be associated with antiobesity activity of KDC and FBT. In particular, KDC could reduce the relative abundance of Erysipelotrichaceae. FBT could enhance the relative abundance of Bifidobacteriaceae.
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